4//SEC Filing
Morris Arlene 4
Accession 0001562180-24-005020
CIK 0001710072other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 7:26 PM ET
Size
7.5 KB
Accession
0001562180-24-005020
Insider Transaction Report
Form 4
Morris Arlene
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-10+20,594→ 20,594 totalExercise: $17.13From: 2025-06-10Exp: 2034-06-10→ Common Stock (20,594 underlying)
Footnotes (1)
- [F1]100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders.
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001362520
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 7:26 PM ET
- Size
- 7.5 KB